• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2核酸持续阳性的COVID-19患者的T细胞反应特征——一项队列研究

Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study.

作者信息

Yang Jingyi, Zhong Maohua, Hong Ke, Yang Qingyu, Zhang Ejuan, Zhou Dihan, Xia Jianbo, Chen Yao-Qing, Sun Mingbo, Zhao Bali, Xiang Jie, Liu Ying, Han Yang, Xu Mengxin, Zhou Xi, Huang Chaolin, Shang You, Yan Huimin

机构信息

Shanghai Public Health Clinical Center Fudan University Shanghai China.

Joint Laboratory of Infectious Diseases and Health Wuhan Institute of Virology & Wuhan Jinyintan Hospital Wuhan Institute of Virology Center for Biosafety Mega-Science Chinese Academy of Sciences (CAS) Wuhan China.

出版信息

Clin Transl Immunology. 2021 Mar 4;10(3):e1259. doi: 10.1002/cti2.1259. eCollection 2021.

DOI:10.1002/cti2.1259
PMID:33728049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7932004/
Abstract

OBJECTIVE

SARS-CoV-2 has caused a worldwide pandemic of COVID-19. The existence of prolonged SARS-CoV-2 positivity (PP) has further increased the burden on the health system. Since T cells are vital for viral control, we aimed to evaluate the characteristics of T-cell responses associated with PP.

METHODS

We established a PP cohort and two age- and sex-matched control cohorts: a regular clinical recovery (CR) cohort and a healthy donor (HD) cohort. The mean time for RNA negativity conversion in the PP cohort was markedly longer than that in the CR cohort (66.2 vs 25.3 days), while the time from illness onset to sampling was not significantly different. T-cell responses in the PP cohort were assayed, analysed and compared with those in the CR and HD cohorts by flow cytometry and ELISpot analysis of peripheral blood mononuclear cells.

RESULTS

Compared with the CR cohort, the proliferation, activation and functional potential of CD8 and CD4 T cells in the PP cohort were not significantly different. However, the frequencies and counts of Teff and Tem in CD8 but not in CD4 T cells of the PP cohort were prominently lower. Moreover, a weaker SARS-CoV-2 N protein-specific IFN-γ T-cell response and a higher frequency of Tregs were detected in the PP cohort.

CONCLUSION

Suppressed CD8 T-cell differentiation is associated with PP and may be an indicator for the prediction of prolonged SARS-CoV-2 positivity in COVID-19 patients. The association between suppressed CD8 T-cell differentiation and elevated Tregs warrants studies in the future.

摘要

目的

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)已引发了全球范围内的2019冠状病毒病(COVID-19)大流行。SARS-CoV-2长期阳性(PP)的存在进一步加重了卫生系统的负担。由于T细胞对病毒控制至关重要,我们旨在评估与PP相关的T细胞反应特征。

方法

我们建立了一个PP队列以及两个年龄和性别匹配的对照队列:一个常规临床康复(CR)队列和一个健康供体(HD)队列。PP队列中RNA转阴的平均时间明显长于CR队列(66.2天对25.3天),而从发病到采样的时间无显著差异。通过对外周血单个核细胞进行流式细胞术和酶联免疫斑点分析,对PP队列中的T细胞反应进行检测、分析并与CR和HD队列进行比较。

结果

与CR队列相比,PP队列中CD8和CD4 T细胞的增殖、活化及功能潜力无显著差异。然而,PP队列中CD8而非CD4 T细胞的效应性T细胞(Teff)和记忆性T细胞(Tem)的频率和数量显著更低。此外,在PP队列中检测到较弱的SARS-CoV-2 N蛋白特异性干扰素-γ T细胞反应以及更高频率的调节性T细胞(Tregs)。

结论

CD8 T细胞分化受抑制与PP相关,可能是预测COVID-19患者SARS-CoV-2长期阳性的一个指标。CD8 T细胞分化受抑制与Tregs升高之间的关联值得未来进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/beed02401134/CTI2-10-e1259-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/ad76a9bb42fe/CTI2-10-e1259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/a64e172a7d13/CTI2-10-e1259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/cf4126b6bb8b/CTI2-10-e1259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/f9d35155f57b/CTI2-10-e1259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/ea0d8ad1f8b0/CTI2-10-e1259-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/beed02401134/CTI2-10-e1259-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/ad76a9bb42fe/CTI2-10-e1259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/a64e172a7d13/CTI2-10-e1259-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/cf4126b6bb8b/CTI2-10-e1259-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/f9d35155f57b/CTI2-10-e1259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/ea0d8ad1f8b0/CTI2-10-e1259-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af0c/7932004/beed02401134/CTI2-10-e1259-g006.jpg

相似文献

1
Characteristics of T-cell responses in COVID-19 patients with prolonged SARS-CoV-2 positivity - a cohort study.SARS-CoV-2核酸持续阳性的COVID-19患者的T细胞反应特征——一项队列研究
Clin Transl Immunology. 2021 Mar 4;10(3):e1259. doi: 10.1002/cti2.1259. eCollection 2021.
2
SARS-CoV-2-reactive IFN-γ-producing CD4 and CD8 T cells in blood do not correlate with clinical severity in unvaccinated critically ill COVID-19 patients.血液中 SARS-CoV-2 反应性 IFN-γ 产生的 CD4 和 CD8 T 细胞与未接种疫苗的危重症 COVID-19 患者的临床严重程度无关。
Sci Rep. 2022 Aug 22;12(1):14271. doi: 10.1038/s41598-022-18659-x.
3
Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study.COVID-19 康复后 6 个月内 T 细胞表型和反应的改变:一项队列研究。
Virol Sin. 2021 Oct;36(5):859-868. doi: 10.1007/s12250-021-00348-0. Epub 2021 Feb 9.
4
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study.奥密克戎 BA.1 特异性 T 细胞应答在香港接种科兴或辉瑞疫苗的成年人中的观察性队列研究。
Lancet Microbe. 2023 Jun;4(6):e418-e430. doi: 10.1016/S2666-5247(23)00006-X. Epub 2023 Apr 20.
5
COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity.COVID-19 患者的淋巴细胞亚群发生变化,功能失调的 CD8lo T 细胞频率更高,与疾病严重程度相关。
Front Immunol. 2023 Sep 21;14:1223730. doi: 10.3389/fimmu.2023.1223730. eCollection 2023.
6
Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.对 SARS-CoV-2 特异性 T 细胞细胞因子产生反应进行为期 1 年的纵向评估显示,多细胞因子增殖反应具有持久性,且与疾病严重程度相关的免疫应答更强。
J Virol. 2022 Jul 13;96(13):e0050922. doi: 10.1128/jvi.00509-22. Epub 2022 Jun 14.
7
Immune monitoring of SARS-CoV-2-specific T cell and B cell responses in patients with multiple sclerosis treated with ocrelizumab.奥瑞珠单抗治疗多发性硬化症患者的 SARS-CoV-2 特异性 T 细胞和 B 细胞反应的免疫监测。
Front Immunol. 2023 Sep 20;14:1254128. doi: 10.3389/fimmu.2023.1254128. eCollection 2023.
8
Performance comparison of a flow cytometry immunoassay for intracellular cytokine staining and the QuantiFERON® SARS-CoV-2 test for detection and quantification of SARS-CoV-2-Spike-reactive-IFN-γ-producing T cells after COVID-19 vaccination.流式细胞术免疫分析与 QuantiFERON® SARS-CoV-2 试验在检测和定量 COVID-19 疫苗接种后 SARS-CoV-2 刺突反应性 IFN-γ 产生 T 细胞方面的性能比较。
Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):657-662. doi: 10.1007/s10096-022-04422-7. Epub 2022 Feb 15.
9
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.符合药品生产质量管理规范的严重急性呼吸综合征冠状病毒2细胞毒性T淋巴细胞的制造与表征
J Infect Dis. 2023 Mar 28;227(6):788-799. doi: 10.1093/infdis/jiac500.
10
SARS-CoV-2-reactive interferon-γ-producing CD8+ T cells in patients hospitalized with coronavirus disease 2019.COVID-19 住院患者中针对 SARS-CoV-2 的干扰素-γ产生的 CD8+ T 细胞。
J Med Virol. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. Epub 2020 Jul 2.

引用本文的文献

1
Time-resolved scRNA-seq reveals transcription dynamics of polarized macrophages with influenza A virus infection and antigen presentation to T cells.时间分辨 scRNA-seq 揭示了甲型流感病毒感染和抗原呈递给 T 细胞的极化巨噬细胞的转录动力学。
Emerg Microbes Infect. 2024 Dec;13(1):2387450. doi: 10.1080/22221751.2024.2387450. Epub 2024 Sep 1.
2
Cellular Immunity of SARS-CoV-2 in the Borriana COVID-19 Cohort: A Nested Case-Control Study.博里亚纳新冠病毒肺炎队列中新冠病毒 2 型的细胞免疫:一项巢式病例对照研究
Epidemiologia (Basel). 2024 Apr 10;5(2):167-186. doi: 10.3390/epidemiologia5020012.
3
A quest for universal anti-SARS-CoV-2 T cell assay: systematic review, meta-analysis, and experimental validation.

本文引用的文献

1
Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19.从新冠肺炎临床康复的个体中淋巴细胞的广泛表型改变及潜在功能障碍
J Mol Cell Biol. 2021 Jul 6;13(3):197-209. doi: 10.1093/jmcb/mjab014.
2
Adaptive immunity to SARS-CoV-2 and COVID-19.对 SARS-CoV-2 和 COVID-19 的适应性免疫。
Cell. 2021 Feb 18;184(4):861-880. doi: 10.1016/j.cell.2021.01.007. Epub 2021 Jan 12.
3
Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19.
寻求通用的抗SARS-CoV-2 T细胞检测方法:系统评价、荟萃分析和实验验证。
NPJ Vaccines. 2024 Jan 2;9(1):3. doi: 10.1038/s41541-023-00794-9.
4
Regulatory T Cells (Tregs) and COVID-19: Unveiling the Mechanisms, and Therapeutic Potentialities with a Special Focus on Long COVID.调节性T细胞(Tregs)与新冠病毒病(COVID-19):揭示其机制及治疗潜力,特别关注新冠后综合征
Vaccines (Basel). 2023 Mar 19;11(3):699. doi: 10.3390/vaccines11030699.
5
Immune cell landscape in symptomatic and asymptomatic SARS-CoV-2 infected adults and children in urban Dhaka, Bangladesh.孟加拉国达卡市有症状和无症状的 SARS-CoV-2 感染成年和儿童的免疫细胞图谱。
Immunobiology. 2023 Mar;228(2):152350. doi: 10.1016/j.imbio.2023.152350. Epub 2023 Feb 18.
6
Severely ill and high-risk COVID-19 patients exhibit increased peripheral circulation of CD62L+ and perforin+ T cells.严重感染 COVID-19 且具有高危因素的患者外周血循环中 CD62L+ 和穿孔素+T 细胞增多。
Front Immunol. 2023 Feb 2;14:1113932. doi: 10.3389/fimmu.2023.1113932. eCollection 2023.
7
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: Multilayered cross-talks in the setting of coinfections and comorbidities.新型冠状病毒感染对肺血管的潜在长期影响:合并感染和合并症背景下的多层次串扰。
PLoS Pathog. 2023 Jan 12;19(1):e1011063. doi: 10.1371/journal.ppat.1011063. eCollection 2023 Jan.
8
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?恢复期 COVID-19 患者调节性 T 细胞动态的范围综述——提示其可能参与长新冠的发生?
Front Immunol. 2022 Dec 13;13:1070994. doi: 10.3389/fimmu.2022.1070994. eCollection 2022.
9
Publication trends of research on COVID-19 and host immune response: A bibliometric analysis.COVID-19 与宿主免疫反应研究的发表趋势:文献计量分析。
Front Public Health. 2022 Aug 8;10:939053. doi: 10.3389/fpubh.2022.939053. eCollection 2022.
10
The Dynamic Role of FOXP3 Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection.FOXP3+Tregs 的动态作用及其在 SARS-CoV-2 感染期间的潜在治疗应用。
Front Immunol. 2022 Jul 8;13:916411. doi: 10.3389/fimmu.2022.916411. eCollection 2022.
COVID-19 患者中严重急性呼吸综合征冠状病毒 2 的持续脱落。
Emerg Microbes Infect. 2020 Dec;9(1):2571-2577. doi: 10.1080/22221751.2020.1852058.
4
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.急性 COVID-19 患者中针对 SARS-CoV-2 的抗原特异性适应性免疫反应,及其与年龄和疾病严重程度的关联。
Cell. 2020 Nov 12;183(4):996-1012.e19. doi: 10.1016/j.cell.2020.09.038. Epub 2020 Sep 16.
5
Broad and strong memory CD4 and CD8 T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.在 COVID-19 之后,英国康复个体中 SARS-CoV-2 诱导产生的广泛而强大的记忆性 CD4 和 CD8 T 细胞。
Nat Immunol. 2020 Nov;21(11):1336-1345. doi: 10.1038/s41590-020-0782-6. Epub 2020 Sep 4.
6
Longitudinal Characteristics of T Cell Responses in Asymptomatic SARS-CoV-2 Infection.无症状SARS-CoV-2感染中T细胞反应的纵向特征
Virol Sin. 2020 Dec;35(6):838-841. doi: 10.1007/s12250-020-00277-4. Epub 2020 Aug 21.
7
T cell responses in patients with COVID-19.新冠病毒肺炎患者的T细胞反应
Nat Rev Immunol. 2020 Sep;20(9):529-536. doi: 10.1038/s41577-020-0402-6. Epub 2020 Jul 29.
8
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.深度免疫剖析 COVID-19 患者,揭示具有治疗意义的不同免疫类型。
Science. 2020 Sep 4;369(6508). doi: 10.1126/science.abc8511. Epub 2020 Jul 15.
9
Reappearance of effector T cells is associated with recovery from COVID-19.效应 T 细胞的再现与 COVID-19 的康复有关。
EBioMedicine. 2020 Jul;57:102885. doi: 10.1016/j.ebiom.2020.102885. Epub 2020 Jul 7.
10
Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment.生成一种广泛适用于 COVID-19 发病机制、疫苗接种和治疗的模型。
Cell. 2020 Aug 6;182(3):734-743.e5. doi: 10.1016/j.cell.2020.06.010. Epub 2020 Jun 10.